Unlike other tumors, breast cancer can also be treated by endocrine therapy beside conventional treatments such as surgery, radiotherapy and chemotherapy. Endocrine therapy is applied to the whole treatment process of breast cancer patients from early adjuvant treatment to postoperative adjuvant treatment and recurrence salvage in clinical practice because it boasts good curative effect and can greatly reduce the risk of cancer coming back. Endocrine therapy for breast cancer is mainly achieved by oral medications.

Drugs for breast cancer endocrine therapy are divided into three categories, estrogen receptor modulators, aromatase inhibitors and estrogen receptor down-regulators. Anastrozole belongs to the second category and is indicated for the treatment of advanced breast cancer in postmenopausal women. Patients who are estrogen receptor negative but tamoxifen positive can take it. Anastrozole is also indicated for the adjuvant treatment of estrogen receptor-positive early-stage breast cancer in postmenopausal women.

Anastrozole was developed by AstraZeneca with Arimidex as its trade name. And it was first marketed in the United States in 1995, approved by the FDA of U.S. for the treatment of advanced breast cancer in postmenopausal women. 1999 saw the introduction of AstraZeneca’s anastrozole into China, where it was approved for use in the adjuvant treatment of estrogen receptor-positive early-stage breast cancer in postmenopausal women. In the following years, generic versions of anastrozole were launched by local Chinese companies. According to CRI’s market research, AstraZeneca still occupied more than 80% of China’s anastrozole market share in 2020 in terms of market value, thus having a huge competitive advantage.

According to CRI’s survey data, the sales value of anastrozole in China kept increasing year by year from 2016 to 2020, not much impacted by COVID-19. In 2020, the sales value of anastrozole in China was about CNY452 million, with a CAGR of 12.1% from 2016 to 2020.

CRI expects that with the rising incidence of breast cancer in China, anastrozole still has significant room for growth in the Chinese market. In addition, compared with other drugs of the same category, anastrozole has been clinically used earlier and is reimbursable under the medical insurance with little cost, and it has relatively fewer side effects as well. Some studies suggest that anastrozole may reduce the risk of invasive estrogen receptor-positive breast cancer and ductal carcinoma in situ in a high-risk postmenopausal breast population. New indications for anastrozole are also expected to be approved in China soon. According to CRI’s estimation, from 2021 to 2025, the sales volume and value of anastrozole in China will continue to grow.

Topics Covered:

• The Impact of COVID-19 on China’s Anastrozole Market
• Development Environment of Anastrozole in China
• Sales Volume of Anastrozole in China
• Sales Volume and Value of Anastrozole in China by Region
• Major Anastrozole Manufacturers in China and Their Market Share
• Sales Price of Anastrozole in China
• Prospects of China’s Anastrozole Market, 2021-2025

The post Research Report on China’s Anastrozole Market, 2021-2025 first appeared on CRI Report.

Market Overview
The global Microcrystalline Cellulose Market is expected to exhibit a healthy CAGR of 6.78% to surpass USD 1,204.7 Million by the forecast period 2027. Microcrystalline cellulose (MCC) is a refined wood mash utilized as an enemy of a building up specialist, an emulsifier, a fat substitute, a texturizer, an extender, and a building specialist. It is ordinarily utilized as tablets or enhancements. It is created by controlled hydrolysis of profoundly filtered alpha-cellulose, acquired from normally happening wood cellulose with mineral acids. Microcrystalline cellulose is also applicable in personal care and cosmetic products, creating profitable opportunities for market players.
Microcrystalline Cellulose Market is expected to witness a substantial market growth rate during the forecast period. The regional market growth is driven by the increasing demand for MCC as pharmaceutical excipients. Moreover, the increasing food & beverage industry, changing consumer lifestyles, growing per capita disposable income, and rising purchasing power of the people are expected to witness the largest market growth of the microcrystalline cellulose market during the forecast period. However, the availability of microcrystalline cellulose substitutes is expected to restrain the growth of this market.
Market Segmentation
Global Microcrystalline Cellulose Market has been classified into Source, End-Use Industry, and Region.
Based on source type, the Global Microcrystalline Cellulose Market has been divided into wood-based and non-wood-based. The wood-based source segment is expected to register the highest market growth owing to more than 50% of the global market share in 2019. This polymer is widely used as a non-stick coating for pans and cookware, insulation of wiring in aerospace and electrical industries, medical appliances, and automotive and industrial products.
In terms of the end-use industry, the microcrystalline cellulose market has been classified into pharmaceutical, food & beverages, cosmetics & personal care, and others. The pharmaceutical segment led the global market with more than 40% market share in 2019. among people. The food & beverage segment is evaluated to hold a significant market share in the global microcrystalline cellulose market.
Regional Analysis
Geographically, the Microcrystalline Cellulose Market has been spread across five regions, namely, Asia-Pacific, North America, Europe, Latin America, and the Middle East & Africa.
The market in Asia-Pacific accounted for the largest market share of more than 40% market in 2019, with a market value of approximately USD 587.3 million. The regional market growth is driven by the increasing urbanization and growing industrialization in the developing economies of Asia-Pacific, especially in China, Japan, and southeast Asian nations.
North America held the second-largest market share owing to the existence of established players in the region, with the US being the largest market.
Major Players
The Major players operating in the global microcrystalline cellulose market are DuPont, Asahi Kasei Corporation, JRS Pharma, Roquette Frères, Mingtai Chemical Co., Ltd., Accent Microcell Pvt. Ltd., JRS Pharma, Pharmatrans-Sanaq AG, DFE Pharma, Weiming Pharmaceutical MFG. Co., Ltd, and Sigachi Industries Pvt. Ltd.
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

The post Global Microcrystalline Cellulose Market first appeared on CRI Report.

Market Overview
According to Market Research Future Analysis, the Global Adaptive Headlights Market is expected to witness a notable market growth at 20.42% CAGR during the review period to surpass a value of USD 4,388.9 Million by 2026. Adaptive headlights are the technological advancements in headlights intended to create driving at night and other low-light conditions safe by rising the visibility around curves and over hills. The growth of the global market is attributed to the vendors is dependent on market conditions, government support, and industrial development. Therefore, the major manufacturers should focus on expanding their presence and enhancing their services during the review period.
The global adaptive headlights market is anticipated to register a healthy market growth during the review period. The global market growth is driven by the increase in the number of road accidents and growing awareness regarding vehicle safety. However, the demand for adaptive headlights is limited in certain regions where the vehicle’s cost is still a more prominent factor than the safety of the driver and vehicle. Laser lighting as one of the future headlamp solutions is one of the most promising advancements in automotive lighting and the next major move after halogen, xenon, and LED headlight technologies. The prime benefit of laser lights is that their brightness is almost four times that of an LED.

Market Segmentation
Global Adaptive Headlights Market has been categorized based on Type, Vehicle Type, and Sales Channel.
In terms of type segment, the global adaptive headlights market has been categorized into LED, xenon, and halogen. The halogen segment is expected to register a 17.64% CAGR during the forecast period. Based on the vehicle type segment, the global market has been classified into passenger cars and commercial vehicles.
Based on vehicle type, the global Adaptive Headlights market has been bifurcated into passenger cars and commercial vehicles. By sales channel type, the global adaptive headlights market has been subdivided into OEM and aftermarket.
Regional Analysis
Geographically, the report on the adaptive headlights market has been spread across Asia-Pacific, North America, Europe, and the rest of the world.
Europe is likely to register the largest market with the largest market owing to the major adaptive headlight players, such as Robert Bosch GmbH, HELLA GmbH & Co. KGaA, OSRAM Licht AG, and Valeo, are headquartered in this region. The regional market has been spread across Germany, France, the UK, Italy, and Spain. Moreover, the growing demand for headlights, parts, and components from premium German OEMs, such as Mercedes, Audi, and BMW, pushes global market players to increase and develop their operation network in Europe.
Asia-Pacific is expected to contribute to the second largest market owing to the increasing vehicle production plants and distribution networks in the region. The regional market growth industry is driven by the growing automobile manufacturing industry, especially in countries such as China, India, and Malaysia.
Major Players
The major players of the global market include Robert Bosch GmbH, General Electric, HELLA GmbH & Co. KGaA, Koito Manufacturing Co., Ltd., OSRAM Licht AG, and Valeo.
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

The post Global Adaptive Headlights Market Research Report – Forecast till 2026 first appeared on CRI Report.